Sub menu

 
 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset.

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

1062 result(s) found, displaying 251 to 275

  • AusPAR: Durvalumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Durvalumab

  • AusPAR: Follitropin alfa

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Follitropin alfa

  • AusPAR: Mogamulizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Mogamulizumab

  • AusPAR: Olaparib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Olaparib

  • AusPAR: Omalizumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Omalizumab

  • AusPAR: Adalimumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Adalimumab

  • AusPAR: Rituximab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Rituximab

  • AusPAR: Forxiga

    Australian Public Assessment Report (AusPAR)
    Forxiga (dapagliflozin) has been approved for the treatment of symptomatic heart failure with reduced ejection fraction, as an adjunct to standard of care therapy, in adults.

  • AusPAR: Guselkumab

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Guselkumab

  • AusPAR: Ciclosporin

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Ciclosporin

  • AusPAR: Labetalol hydrochloride

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Labetalol hydrochloride

  • AusPAR: Tucatinib

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Tucatinib

  • AusPAR: Trifarotene

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Trifarotene

  • AusPAR: Afamelanotide

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Afamelanotide

  • AusPAR: Brexpiprazole

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Brexpiprazole

  • AusPAR: Insulin aspart

    Australian Public Assessment Report (AusPAR)
    Australian Public Assessment Report for Insulin aspart

Help us improve the Therapeutic Goods Administration site